Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment 5. Debunking Myths in the US Healthcare System
Top Ten Searches
aldosteronism contrast dialysis vitamin d bicarbonate arf amyloidosis hypocalcemia renal artery husYour Article Summary
Renal neuroendocrine tumors
Indian Journal of Urology, 06/25/09
Lane BR et al. - A spectrum of NETs can rarely occur in the kidney. Renal carcinoids have a variable clinical course; SCC and LCNEC are associated with poor clinical outcomes. Diagnosis of NETs, especially LCNEC, requires awareness of their rare occurrence and prudent use of immunohistochemical neuroendocrine markers.
Related Articles
Miscellaneous Cancers (Lung, Thyroid, Renal Cancer, Myeloma, and Neuroendocrine Tumors): Role of SPECT and PET in Imaging Bone Metastases
Seminars in Nuclear Medicine, 10/14/09
Relevance Score: 67%
High-dose Octreotide Acetate for Management of Gastroenteropancreatic Neuroendocrine Tumors
Anticancer Research, 11/11/09
Relevance Score: 66%
Continuous 5-fluorouracil infusion plus long acting Octreotide in advanced well differentiated neuroendocrine carcinomas. A phase II trial of the Piemonte Oncology Network.
BMC Cancer, 11/09/09
Relevance Score: 66%
Liver Metastases of Neuroendocrine Tumors: Treatment With Hepatic Transarterial Chemotherapy Using Two Therapeutic Protocols
American Journal of Roentgenology, 10/08/09
Relevance Score: 66%
Targeting the mTOR Pathway in Neuroendocrine Tumors
Clinical Journal of Oncology Nursing, 10/07/09
Relevance Score: 65%
Today in Endocrinology...keeping you current
Receive free subspecialty "5-minute updates" via email
Stone composition and metabolic status
Urological Research - Urolithiasis, 11/25/09
A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease
New England Journal of Medicine, 11/20/09
Addition of Angiotensin Receptor Blockade or Mineralocorticoid Antagonism to Maximal Angiotensin-Converting Enzyme Inhibition in Diabetic Nephropathy
Journal of the American Society of Nephrology, 11/20/09
Today in Hematology/Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Stage migration and increasing proportion of favorable-prognosis metastatic renal cell carcinoma patients
Cancer, 11/25/09
The role of lymphovascular space invasion in renal cell carcinoma as a prognostic marker of survival after curative resection
Urologic Oncology: Seminars and Original Investigations, 11/25/09
Juxtaglomerular cell tumor of the kidney--a new classification scheme
Urologic Oncology: Seminars and Original Investigations, 11/25/09
Article Search
Sponsor


See Latest Articles


